Cube Dx is located in St. Valentin (Austria). Cube Dx entirely new multiplex technology - the hybcell – is the world's first cylindrical microarray – delivers speedy and reliable results with minimal effort. The hyborg – a completely automated device – processes the samples fully independently and without any intervention by the user. The Cube Dx assay is based on compact sequencing and is designed to address especially those complex diagnostic challenges where fast answers are essential.
R&D:The company focuses on the development, production and distribution of multiplex tests for in-vitro diagnostics in clinical routine. Multiplex diagnostics allow for the identification in parallel of a variety of significant parameters (bacteria, fungi, resistance markers, etc.) in a single test, requiring only a minimal amount of sample material.
Production:Cube Dx manufactures its hybcell diagnostic kits in Austria and relies on a network of reputed suppliers located in Europe.
Services:Cube Dx offers collaborations and services for the development and implementation of multiplex DNA/RNA or protein based diagnostic assays.
Sales/Distribution:Currently Cube Dx' products are distributed in central Europe and the Middle East. Further expansion of its distribution network in Europe and in major global life science markets is intended.
Westbahnstr. 55
4300 St. Valentin
Upper Austria
Contact: Bernhard Ronacher (CSO)
Email: info@cubedx.com
Website